Taurine in Peripartum Cardiomyopathy

• Status: Completed
• Trial end date: 2020-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

Taurine as an adjunct for early left ventricular recovery in peripartum cardiomyopathy

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ain Shams University

Criteria

Inclusion Criteria:

• Peripartum Cardiomyopathy

Exclusion Criteria:

• Other identifiable cause for heart failure

• low LVEF ≤ 25%

• sepsis

• autoimmune disease

• severe chronic disease

• malignancy